Atypical antipsychotic drugs selectively increase neurotensin efflux in dopamine terminal regions
AUTOR(ES)
Radke, James M.
FONTE
The National Academy of Sciences
RESUMO
Typical antipsychotic drugs, such as haloperidol and chlorpromazine, increase synthesis of the neuropeptide neurotensin (NT) in both the striatum and the nucleus accumbens, whereas atypical antipsychotic drugs, such as clozapine and olanzapine, do so only in the nucleus accumbens. By using in vivo microdialysis, we now report that acute administration of haloperidol, clozapine, or olanzapine failed to alter the release of NT in either the striatum or nucleus accumbens. In contrast, chronic administration of haloperidol for 21 days increased NT release in both the striatum and nucleus accumbens, whereas treatment for 21 days with the atypical antipsychotic drugs, clozapine or olanzapine, increased NT release selectively in the nucleus accumbens. These findings suggest that (i) increased NT mRNA expression and NT tissue concentrations are associated with increases in the extracellular fluid concentrations of the peptide and (ii) atypical antipsychotic drugs may exert their therapeutic effects and produce fewer side effects by virtue of their selectivity in limbic compared with striatal, target neurons.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21665Documentos Relacionados
- Neurotensin-deficient mice show altered responses to antipsychotic drugs
- Cognition, schizophrenia, and the atypical antipsychotic drugs
- Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
- Dopamine-Sensitive Adenylate Cyclase in Mammalian Brain: A Possible Site of Action of Antipsychotic Drugs
- Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study
